← All diseases
Cancer
Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2862)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Splenic Granulomatous Lesions Mimicking Metastases on 18 F-FDG PET/CT in a Patient With Ovarian Cancer. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimizing the MRI Pelvis Protocol for O-RADS MRI. (2026/09/01) ♡
- Arginine restriction exploits DNMT3B-ASS1-driven arginine auxotrophy and mTORC1-suppressed autophagy to overcome niraparib resistance in ovarian cancer. (2026/08/28) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta-Analysis of Over 720,000 Participants in the ABACus 2 Consortium. (2026/08/15) ♡
- Therapeutic Potential of Solanum macrocarpon in Uterine Leiomyoma: In Vivo and In Silico Approaches. (2026/08/15) ♡
- A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor. (2026/08/10) ♡
- Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic imaging of adnexal lesions in pregnancy: systematic review. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. ADP-ribosylation: An emerging regulator of the epigenome. (2026/08/10) ♡
- PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy. (2026/08/10) ♡
- Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction. (2026/08/10) ♡
- AKAP12 as a signal-compartmentalizing Hub across diseases: Context-dependent functions and translational potential. (2026/08/09) ♡
- From ACR O-RADS 2022 to Explainable Deep Learning: Comparative Performance of Expert Radiologists, Convolutional Neural Networks, Vision Transformers, and Fusion Models for Ultrasound-Based Risk Stratification of Ovarian Masses. (2026/08/09) ♡
- A clinical-radiomics model based on MRI sub-regions of gluteus maximus for recurrence prediction in high-grade serous ovarian cancer. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Detection, occurrence, development, diagnosis and treatment of vaginal microbiome in gynecological cancers. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clear Cell Carcinoma of the Left Colon: A Case Report. (2026/08/07) ♡
- Risk Factors for Estrogen Receptor Subtype-Specific Contralateral Breast Cancer in Women Under Age 55 Years. (2026/08/07) ♡
- Folate Receptor Alpha (FRα/FOLR1) Immunohistochemical Expression Across Molecularly Classified Endometrial Carcinomas. (2026/08/07) ♡
- Tetraniline-Engineered Nickel Molecular Frameworks for Combinatorial NIR-Triggered Photothermal and Photodynamic Cancer Therapy. (2026/08/07) ♡
- Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study. (2026/08/07) ♡
- Factors associated with non-completion of gynecological cancer clinical trials. (2026/08/07) ♡
- Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia. (2026/08/06) ♡
- A novel tRNA-derived fragment, tRF-19-79MP9PJZ, promotes uterine corpus endometrial carcinoma progression by targeting DSC3. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dedifferentiated Liposarcoma Presenting as Primary Diffuse Peritoneal Sarcomatosis: A Case Report and Literature Review. (2026/08/06) ♡
- Systems genetics approaches model the heritable architecture of polyendocrine metabolic ovarian syndrome. (2026/08/06) ♡
- Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project. (2026/08/06) ♡
- Tumor-specific immunological and pathological changes in layer chickens affected with ovarian adenocarcinoma. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overcoming immune resistance through tumor microenvironment reprogramming: Emerging immunotherapeutic strategies and translational advances. (2026/08/06) ♡
- Normal Tissue Dosimetry of Intraperitoneal (224)Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Imaging patterns and diagnostic challenges in metastatic invasive lobular carcinoma. (2026/08/06) ♡
- Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer. (2026/08/05) ♡
- A tumour-derived organoid biobank maps cancer gene dependencies. (2026/08/05) ♡
- Protocol for culture of zebrafish developing ovaries as an ex vivo system for investigating early oogenesis and ovarian development. (2026/08/05) ♡
- Symptom burden and symptom clusters in ovarian cancer patients during first-line maintenance therapy: a cross-sectional survey. (2026/08/04) ♡
- Pharmacological evaluation reveals distinct anti-proliferative and migration-associated effects of curcumin analogues B-143 and B-155 in ovarian cancer cells. (2026/08/04) ♡
- Opportunities to improve detection of genetic predisposition for ovarian cancer applying the Tumor-First workflow. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials. (2026/08/04) ♡
- Folate Receptor Immunohistochemical Staining Heterogeneity in Gynecologic Cancers. (2026/08/04) ♡
- Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance. (2026/08/04) ♡
- Size-exclusion chromatography as a clinically applicable method for extracellular vesicles collection as liquid biopsies shows potential diagnostic relevance and correlation with poorer outcome in common cancer types. (2026/08/04) ♡
- LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis. (2026/08/04) ♡
- CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept. (2026/08/04) ♡
- Retrospective assessment of TCF12 expression in early invasive breast cancer and ovarian cancer: prognostic implications and biological insights. (2026/08/04) ♡
- L-cysteine selenium nanoparticles induce apoptosis in ovarian cancer cells by activating the FOXO3a/GADD45A pathway. (2026/08/04) ♡
- Robotic-assisted resection of pediatric intracavitary lesions: expanding the boundaries of minimally invasive surgery. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sensitive detection of unopposed estrogen using estrogen receptor functionalized nanoprobes for cancer diagnosis. (2026/08/03) ♡
- PARP inhibition induces a redox-dependent dormant reservoir vulnerable to disulfiram in high-grade serous ovarian cancer. (2026/08/03) ♡
- Integrative transcriptomics and single-cell analysis identify SIX4 as a candidate epithelial target in ovarian cancer and PCOS-associated ovarian dysregulation. (2026/08/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer. (2026/08/03) ♡
- Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026). (2026/08/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.